Nutriband Inc.

NasdaqCM:NTRB Stock Report

Market Cap: US$45.3m

Nutriband Management

Management criteria checks 4/4

Nutriband's CEO is Gareth Sheridan, appointed in Jan 2016, has a tenure of 8.92 years. total yearly compensation is $257.11K, comprised of 58.3% salary and 41.7% bonuses, including company stock and options. directly owns 15.86% of the company’s shares, worth $7.19M. The average tenure of the management team and the board of directors is 6.4 years and 6.4 years respectively.

Key information

Gareth Sheridan

Chief executive officer

US$257.1k

Total compensation

CEO salary percentage58.3%
CEO tenure8.9yrs
CEO ownership15.9%
Management average tenure6.4yrs
Board average tenure6.4yrs

Recent management updates

Recent updates

Is Nutriband (NASDAQ:NTRB) A Risky Investment?

Mar 31
Is Nutriband (NASDAQ:NTRB) A Risky Investment?

Is Nutriband (NASDAQ:NTRB) Weighed On By Its Debt Load?

Sep 13
Is Nutriband (NASDAQ:NTRB) Weighed On By Its Debt Load?

Nutriband GAAP EPS of -$0.12, revenue of $0.5M

Sep 08

Nutriband opens a new branch in Ecuador with plans to expand into the South American market

Jul 22

Nutriband: Advancing Transdermal Delivery Of Injectable Drugs

Nov 01

Does Nutriband (NASDAQ:NTRB) Have A Healthy Balance Sheet?

Oct 06
Does Nutriband (NASDAQ:NTRB) Have A Healthy Balance Sheet?

CEO Compensation Analysis

How has Gareth Sheridan's remuneration changed compared to Nutriband's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2024n/an/a

-US$7m

Apr 30 2024n/an/a

-US$6m

Jan 31 2024US$257kUS$150k

-US$5m

Oct 31 2023n/an/a

-US$5m

Jul 31 2023n/an/a

-US$5m

Apr 30 2023n/an/a

-US$5m

Jan 31 2023US$379kUS$200k

-US$4m

Oct 31 2022n/an/a

-US$7m

Jul 31 2022n/an/a

-US$7m

Apr 30 2022n/an/a

-US$7m

Jan 31 2022US$311kUS$149k

-US$6m

Oct 31 2021n/an/a

-US$5m

Jul 31 2021n/an/a

-US$3m

Apr 30 2021n/an/a

-US$3m

Jan 31 2021US$210kUS$60k

-US$3m

Oct 31 2020n/an/a

-US$2m

Jul 31 2020n/an/a

-US$2m

Apr 30 2020n/an/a

-US$3m

Jan 31 2020US$57kUS$42k

-US$3m

Oct 31 2019n/an/a

-US$2m

Jul 31 2019n/an/a

-US$2m

Apr 30 2019n/an/a

-US$3m

Jan 31 2019US$88kUS$88k

-US$3m

Compensation vs Market: Gareth's total compensation ($USD257.11K) is below average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Gareth's compensation has been consistent with company performance over the past year.

CEO

Gareth Sheridan (34 yo)

8.9yrs

Tenure

US$257,110

Compensation

Mr. Gareth Sheridan has been Chief Executive Officer and Director of Nutriband Inc. since 2016. Mr. Sheridan founded Nutriband Ltd., in 2012 an Irish company which was acquired in 2016. Mr. Sheridan was na...

Leadership Team

NamePositionTenureCompensationOwnership
Serguei Melnik
Founder8.9yrsUS$257.11k7.39%
$ 3.3m
Gareth Sheridan
Founder8.9yrsUS$257.11k15.86%
$ 7.2m
Gerald Goodman
CFO & Chief Accounting Officer6.4yrsUS$192.87k0.78%
$ 352.2k
Alan Smith
COO & President of 4P Therapeutics6yrsUS$201.72k0.38%
$ 171.0k
Jeffrey Patrick
Chief Scientific Officer6.6yrsno data0.33%
$ 149.4k
Michael Myer
President of Pocono Pharmaceuticalno dataUS$115.60kno data
Tyler Overk
Head of Active Intelligenceno datano datano data

6.4yrs

Average Tenure

50yo

Average Age

Experienced Management: NTRB's management team is seasoned and experienced (6.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Serguei Melnik
Founder8.9yrsUS$257.11k7.39%
$ 3.3m
Gareth Sheridan
Founder8.9yrsUS$257.11k15.86%
$ 7.2m
Stefani Mancas
Independent Director6.4yrsUS$15.15k0.13%
$ 57.6k
Mark Hamilton
Independent Director6.4yrsUS$15.15k0.15%
$ 70.2k
Thomas Cooney
Member of Advisory Boardno dataUS$37.00kno data
Srinvas Nalamachu
Member of Advisory Board6.4yrsno datano data
Irina Gram-Contulescu
Independent Director2.9yrsUS$15.15k0.011%
$ 4.8k
Sergei Glinka
Independent Directorless than a yearno data7.43%
$ 3.4m
Radu Bujoreanu
Independent Director5.5yrsno datano data

6.4yrs

Average Tenure

48.5yo

Average Age

Experienced Board: NTRB's board of directors are considered experienced (6.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:22
End of Day Share Price 2024/12/23 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nutriband Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eric BederSmall Cap Consumer Research LLC
Marla MarinZacks Small-Cap Research